1. Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting. (January 2022) Authors: Santoleri, Fiorenzo; Lasala, Ruggero; Ranucci, Elena; Rocchi, Marco; Pulini, Stefano; Morelli, Anna Maria; Spadano, Antonio; Costantini, Alberto Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 1(2022) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. (August 2019) Authors: Capelletto, Enrica; Migliorino, Maria Rita; Morabito, Alessandro; Chiari, Rita; Grossi, Francesco; Tiseo, Marcello; Costanzo, Francesco Di; Delmonte, Angelo; Romano, Gianpiero; Galetta, Domenico; Scotti, Vieri; Gregorc, Vanesa; Pisconti, Salvatore; Ceresoli, Giovanni Luca; Del Conte, Alessandro; ... Journal: Lung cancer Issue: Volume 134(2019) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. (April 2023) Authors: Bertaglia, Valentina; Morelli, Anna Maria; Solinas, Cinzia; Aiello, Marco Maria; Manunta, Silvia; Denaro, Nerina; Tampellini, Marco; Scartozzi, Mario; Novello, Silvia Journal: Critical reviews in oncology/hematology Issue: Volume 184(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗